| Labatec Pharma SA - Atosiban Labatec 6.75 mg / 0.9 ml, solution injectable |
| 69185 | | 01 | | Atosiban Labatec 6.75 mg / 0.9 ml | | solution injectable | | G02CX01 | | Atosiban | | 04.03.2024 | | |
|
| Composition |
| atosibanum 6.75 mg ut atosibani acetas 7.16 mg, mannitolum, acidum hydrochloridum, natrii hydroxidum corresp. natrium 0.86 mg, aqua ad iniectabile q.s. ad solutionem pro 0.9 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Atosiban | 6.75mg / 0.9ml |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum | | Mannitol | | Sodium Hydroxide |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | DDP | DDP | B | | Non |
|
